Substance use disorder data and the special status challenge for AI systems
Substance use disorder records carry federal protections under 42 CFR Part 2 that exceed standard HIPAA rules. Most AI systems training on health data have no mechanism to detect, segment, or honor these restrictions, which means SUD data either gets excluded entirely or mixed in without proper consent governance. Both outcomes damage model accuracy and patient trust.
Substance use disorder records are not like other health data. They carry a separate federal consent framework under 42 CFR Part 2 that predates HIPAA by decades and, in many respects, exceeds it. Any AI system that ingests clinical data without accounting for this distinction is either violating federal law or systematically excluding the records of roughly 46.3 million Americans who met criteria for SUD in 2022, according to SAMHSA's National Survey on Drug Use and Health.
Both failure modes produce bad outcomes. And most health AI pipelines have no mechanism to handle either one.
What makes SUD data different from other health records
42 CFR Part 2 was enacted in 1975 to protect individuals seeking treatment for substance use disorders from discrimination, prosecution, and social stigma. The regulation applies to any program that holds itself out as providing SUD diagnosis, treatment, or referral for treatment and receives federal funding.
Unlike HIPAA, Part 2 requires patient consent for virtually every disclosure. There is no treatment, payment, or operations exception. A patient's SUD records at a federally assisted program cannot be shared with another provider, a payer, or a researcher without specific written authorization. Even within a single health system, SUD data from a Part 2 program may sit behind a separate consent wall.
The 2024 final rule from SAMHSA and HHS aligned certain Part 2 provisions more closely with HIPAA, particularly for treatment, payment, and healthcare operations disclosures. But redisclosure restrictions remain, and the prohibition on using Part 2 records in legal proceedings without patient consent still holds. For AI developers, the practical effect is straightforward: SUD data carries consent obligations that standard HIPAA workflows do not capture.
Why AI systems fail on SUD data today
Most AI training pipelines treat health data as a single category. Records flow from EHRs, claims databases, and registries into de-identification tools and then into model training. The pipeline assumes a uniform consent posture across all records.
SUD data breaks this assumption. A record generated at a Part 2 program may have been shared with a hospital system under a consent that permitted care coordination but did not authorize research, secondary analysis, or commercial model training. When that record enters a bulk data extract, no flag distinguishes it from a diabetes lab result or an orthopedic note.
The consequences are real. As MedPage Today reported in coverage of the broken addiction treatment system facing pregnant and postpartum people, fragmented SUD care already produces gaps in clinical records. AI systems that cannot identify which records carry Part 2 protections will either train on improperly consented data or, more commonly, exclude SUD records entirely to avoid regulatory risk. A 2021 MedPage Today investigation into nurse rehabilitation programs found similarly low engagement with alternative-to-discipline pathways, partly driven by confidentiality fears. The data trust deficit compounds the clinical trust deficit.
This exclusion pattern creates a systematic bias. Models trained without SUD data will underperform on the populations most affected by substance use, including those with co-occurring mental health conditions, chronic pain, and social determinants that correlate with higher healthcare utilization. The result is AI that works least well for patients who need the most help.
The consent governance gap no one is measuring
Consent for SUD data is not binary. A patient may consent to share records with a specific provider. That same patient may not consent to research use. A third consent form may authorize sharing with a health plan for payment purposes but explicitly prohibit redisclosure.
No standard EHR consent field captures this granularity. HL7 FHIR consent resources exist in specification but are rarely implemented at the record level in production systems. The gap between what Part 2 requires and what health IT infrastructure delivers is where AI compliance risk accumulates.
This is not a theoretical concern. HHS's health IT leadership, as discussed in a recent MedPage Today interview with HHS Health IT Czar Thomas Keane, has acknowledged that AI governance and prior authorization reform depend on getting data infrastructure right. SUD data is where that infrastructure is most clearly broken.
What a trust-scored approach changes
Scoring SUD records across consent, provenance, and recency dimensions before they enter any AI pipeline creates a verifiable boundary between compliant and non-compliant use. A record with a valid Part 2 consent for research use, generated within the past 12 months, with clear provenance back to the originating program, scores differently from a record extracted from a bulk claims feed with no consent metadata attached.
This is not about blocking SUD data from AI. The goal is the opposite: making SUD data usable by making it trustworthy. When every record carries a score, developers can set consent floors that honor Part 2 requirements without excluding the entire SUD population from model training. Researchers can query across institutions with confidence that consent governance has been applied at the record level, not assumed at the dataset level.
The Data Trust Index framework weights Consent at 20% of the total score precisely because domains like SUD require granular consent tracking. Provenance, weighted at 25%, matters here because Part 2 records must trace back to the originating program to determine whether the regulation even applies. Without both dimensions scored at the record level, compliance is guesswork.
Key statistics
The cost of getting this wrong
AI developers who ignore the SUD data challenge face three risks simultaneously. First, regulatory exposure under Part 2 for training on improperly consented records. Second, model bias from systematically excluding SUD populations. Third, clinical failure when models deployed in emergency departments, primary care, and behavioral health settings encounter patients whose conditions the training data did not represent.
The path forward is not to treat SUD data as untouchable. It is to build consent-aware, provenance-tracked scoring into the data pipeline before any model trains. That is the difference between exclusion and inclusion with integrity.
The DTI Engine scores every health data record 0-100 across 8 trust dimensions before your AI model sees it. Consent and Provenance together account for 45% of the score, which is exactly why this engine catches what standard de-identification pipelines miss in SUD data. If your team is building AI that touches behavioral health, addiction treatment, or co-occurring disorder populations, and you need consent governance that actually reflects 42 CFR Part 2 requirements, contact Louis Simeonidis at louis@supertruth.ai or (215) 918-4140.
Further reading:
Jason Alan Snyder
Co-founder of SuperTruth and Artists & Robots, and an inventor on the Data Trust Index patents. Twenty-plus years building technology inside Interpublic Group. He writes here nearly every day on data trust, provenance, and what AI should be allowed to act on, and publishes essays on his Substack.
About SuperTruth · LinkedIn · Substack · jasonalansnyder.com
See it in practice
DTI scores the record, not the patient.
8 dimensions. 0–100. Travels with every record permanently.